Overview
- Rocket Lab rallied about 9% in broad space-sector buying tied to SpaceX IPO excitement before its shares came under selling pressure when SpaceX jumped roughly 19% in its market debut and some investors sold smaller space names to buy the new listing.
- The stock’s moves over the past two sessions highlight that investor allocation between large new listings and smaller public space companies can drive sharp, one-day swings that are separate from company performance.
- Company fundamentals remain robust: Rocket Lab reported Q1 revenue of $200.3 million, 63.5% year-over-year growth, a GAAP gross margin near 38.2%, a roughly $2.2 billion backlog, and raised Q2 revenue guidance.
- Corporate milestones may reshape demand and funding choices—Rocket Lab will join the Nasdaq-100 before trading on June 22 and has disclosed an up-to-$3 billion at-the-market equity program while holding more than $1.2 billion in cash and recent government contract wins.
- Key near-term things to watch are Neutron’s maiden-flight progress, which management says is on track for later this year, and whether the company uses its ATM program, because those developments will affect dilution risk, liquidity and investor confidence.